InvestorsObserver
×
News Home

Albireo Pharma Inc (ALBO) Stock Decreases -12.93% This Week; Should You Buy?

Friday, September 25, 2020 10:42 AM | InvestorsObserver Analysts

Mentioned in this article

Albireo Pharma Inc (ALBO) Stock Decreases -12.93% This Week; Should You Buy?

Albireo Pharma Inc (ALBO) stock has risen 50.07% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives ALBO stock a score of 73 out of a possible 100.

That rank is chiefly influenced by a long-term technical score of 96. ALBO's rank also includes a fundamental score of 92. In addition to the average rating from Wall Street analysts, ALBO stock has a mean target price of 69.857. This means analysts expect the stock to climb 106.25% over the next 12 months. The short-term technical score for ALBO is 32.

Overall Score - 73
ALBO has an Overall Score of 73. Find out what this means to you and get the rest of the rankings on ALBO!

What's Happening with ALBO Stock Today

Albireo Pharma Inc (ALBO) stock has risen 4.09% while the S&P 500 has risen 0.14% as of 10:38 AM on Friday, Sep 25. ALBO has risen $1.33 from the previous closing price of $32.54 on volume of 64,246 shares. Over the past year the S&P 500 is up 9.19% while ALBO has risen 50.07%. ALBO lost -$5.92 per share in the over the last 12 months.

Click Here to get the full Stock Score Report on Albireo Pharma Inc (ALBO) Stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App